Japrung et al., 2005 - Google Patents
A simple dual selection for functionally active mutants of Plasmodium falciparum dihydrofolate reductase with improved solubilityJaprung et al., 2005
View HTML- Document ID
- 15367188780887431403
- Author
- Japrung D
- Chusacultanachai S
- Yuvaniyama J
- Wilairat P
- Yuthavong Y
- Publication year
- Publication venue
- Protein Engineering Design and Selection
External Links
Snippet
Sufficient solubility of the active protein in aqueous solution is a prerequisite for crystallization and other structural studies of proteins. In this study, we have developed a simple and effective in vivo screening system to select for functionally active proteins with …
- 108010072292 Plasmodium falciparum DHFR protein 0 title abstract description 120
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/536—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lee et al. | Genetic incorporation of a small, environmentally sensitive, fluorescent probe into proteins in Saccharomyces cerevisiae | |
| US10077433B2 (en) | Permuted and nonpermuted luciferase biosensors | |
| Remy et al. | Detection of protein–protein interactions using a simple survival protein-fragment complementation assay based on the enzyme dihydrofolate reductase | |
| Cabantous et al. | A new protein-protein interaction sensor based on tripartite split-GFP association | |
| Roscoe et al. | Systematic exploration of ubiquitin sequence, E1 activation efficiency, and experimental fitness in yeast | |
| Fan et al. | XRCC1 co‐localizes and physically interacts with PCNA | |
| Siddiqui et al. | Role of the processing pore of the ClpX AAA+ ATPase in the recognition and engagement of specific protein substrates | |
| US20200270586A1 (en) | Multipartite luciferase | |
| JP4262778B2 (en) | Protein fragment complementation assay to detect biomolecular interactions | |
| Frugier et al. | A domain in the N‐terminal extension of class IIb eukaryotic aminoacyl‐tRNA synthetases is important for tRNA binding | |
| JP6110591B2 (en) | Luciferase biosensor for cAMP | |
| US20170219584A1 (en) | Nicotinamide adenine dinucleotide indicators, methods of preparation and application thereof | |
| US20150099271A1 (en) | Fluorescent proteins, split fluorescent proteins, and their uses | |
| Vidal-Aroca et al. | One-step high-throughput assay for quantitative detection of β-galactosidase activity in intact Gram-negative bacteria, yeast, and mammalian cells | |
| EP3191601A1 (en) | Internal protein tags | |
| Dikici et al. | Aequorin variants with improved bioluminescence properties | |
| EP1585961A2 (en) | Molecular sensors by competitive activation | |
| Schanzenbach et al. | Identifying ionic interactions within a membrane using BLaTM, a genetic tool to measure homo-and heterotypic transmembrane helix-helix interactions | |
| Abdalla et al. | Design of a monomeric human glutathione transferase GSTP1, a structurally stable but catalytically inactive protein | |
| Pandey et al. | Combining random gene fission and rational gene fusion to discover near-infrared fluorescent protein fragments that report on protein–protein interactions | |
| Jeon et al. | Cell-based biosensors based on intein-mediated protein engineering for detection of biologically active signaling molecules | |
| Abida et al. | Receptor‐dependence of the transcription read‐out in a small‐molecule three‐hybrid system | |
| Japrung et al. | A simple dual selection for functionally active mutants of Plasmodium falciparum dihydrofolate reductase with improved solubility | |
| Huang et al. | Genetically encoded fluorescent amino acid for monitoring protein Interactions through FRET | |
| Petschnigg et al. | Using yeast as a model to study membrane proteins |